China’s NMPA approves Astellas’ advanced gastric cancer combo therapy

VYLOY is intended for first-line treatment of individuals with a specific type of gastric cancer. Credit: HansMartinPaul on Pixabay.



  • China's NMPA approves Astellas’ advanced gastric cancer combo therapy